InsidersTradesSigma
Follow the 健之佳 share price and the full directors' dealings record of the company, a listed equity based in China. Shares trade on the CN market, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 健之佳 has recorded 13 insider filings. Market capitalisation: €2.4bn. The latest transaction was disclosed on 25 September 2025 (Purchase). Among the most active insiders: 蓝心悦. Every trade is accessible without an account.
13
Insider Decl.
n/a
Thresholds
€452,554
13 ops.
Buy Volume
n/a
n/a
Sell Volume
29Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 8,188 of 29,063 companies
62.4
score / 100
Value85
Quality40
FCF yld42%
Earn yld6.1%
EV/EBITDA5.9x
ROE5.5%
Gross mgn36%
Net mgn1.7%
Debt/EBITDA3.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 25 September 2025
Declarations13 total
13 of 13 declarations
关于 健之佳
健之佳是一家在健康和制药领域运营的公司，在 XSHG 市场上市。该公司专注于药品和保健产品的开发和分销。